{"nct_id":"NCT01850004","title":"Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2014-01-22","start_date_type":"ACTUAL","primary_completion_date":"2017-09-20","primary_completion_date_type":"ACTUAL","completion_date":"2021-10-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["BMY"]}